![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | ISO | RGD:1557831 | 6480464 | ethylene dichloride results in increased expression of GPR161 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1557831 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of GPR161 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of GPR161 mRNA | CTD | PMID:14699072 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of GPR161 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1563245 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPR161 mRNA | CTD | PMID:33387578 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:1563245 | 6480464 | Propylthiouracil results in increased expression of GPR161 mRNA | CTD | PMID:24780913 | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GPR161 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GPR161 mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GPR161 mRNA | CTD | PMID:22100608 | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GPR161 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GPR161 mRNA | CTD | PMID:32699268 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of GPR161 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of GPR161 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of GPR161 mRNA | CTD | PMID:32234424 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GPR161 mRNA | CTD | PMID:20678512 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of GPR161 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | RGD:1563245 | 6480464 | bisphenol A results in increased expression of GPR161 mRNA | CTD | PMID:34947998 | bisphenol A | decreases expression | ISO | RGD:1563245 | 6480464 | bisphenol A results in decreased expression of GPR161 mRNA | CTD | PMID:25181051, PMID:30816183 | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of GPR161 mRNA | CTD | PMID:21120746 | chlordecone | increases expression | ISO | RGD:1557831 | 6480464 | Chlordecone results in increased expression of GPR161 mRNA | CTD | PMID:33711761 | copper atom | multiple interactions | ISO | RGD:1563245 | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of GPR161 mRNA | CTD | PMID:26033743 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of GPR161 mRNA | CTD | PMID:20971185 | copper atom | increases expression | ISO | RGD:1563245 | 6480464 | Copper deficiency results in increased expression of GPR161 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | ISO | RGD:1563245 | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of GPR161 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of GPR161 mRNA | CTD | PMID:20971185 | copper(0) | increases expression | ISO | RGD:1563245 | 6480464 | Copper deficiency results in increased expression of GPR161 mRNA | CTD | PMID:26033743 | Cuprizon | decreases expression | ISO | RGD:1563245 | 6480464 | Cuprizone results in decreased expression of GPR161 mRNA | CTD | PMID:26577399 | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of GPR161 mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of GPR161 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of GPR161 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR161 mRNA | CTD | PMID:27188386 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of GPR161 mRNA | CTD | PMID:21867686 | glycidol | increases expression | ISO | RGD:1563245 | 6480464 | glycidol results in increased expression of GPR161 mRNA | CTD | PMID:24915197 | glyphosate | increases methylation | ISO | RGD:1563245 | 6480464 | glyphosate results in increased methylation of GPR161 gene | CTD | PMID:31011160 | Lasiocarpine | increases expression | EXP | | 6480464 | lasiocarpine results in increased expression of GPR161 mRNA | CTD | PMID:32234424 | methylseleninic acid | increases expression | EXP | | 6480464 | methylselenic acid results in increased expression of GPR161 mRNA | CTD | PMID:18548127 | N-Nitrosopyrrolidine | increases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in increased expression of GPR161 mRNA | CTD | PMID:32234424 | nitrofen | decreases expression | ISO | RGD:1563245 | 6480464 | nitrofen results in decreased expression of GPR161 mRNA | CTD | PMID:33484710 | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GPR161 mRNA more ... | CTD | PMID:32699268 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GPR161 mRNA | CTD | PMID:29067470 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR161 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of GPR161 mRNA | CTD | PMID:15336504 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of GPR161 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR161 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of GPR161 mRNA | CTD | PMID:24935251, PMID:26272509 | triptonide | decreases expression | ISO | RGD:1557831 | 6480464 | triptonide results in decreased expression of GPR161 mRNA | CTD | PMID:33045310 | valproic acid | increases expression | ISO | RGD:1557831 | 6480464 | Valproic Acid results in increased expression of GPR161 mRNA | CTD | PMID:21427059 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of GPR161 mRNA | CTD | PMID:24935251 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of GPR161 mRNA | CTD | PMID:28001369 | |